Vinpocetine
Also known as: Vinca minor extract, ethyl apovincaminate, cavinton, periwinkle extract
Effective Dosage
No established dose for cognitive use; 20-60 mg/day used in clinical studies
What the Science Says
Vinpocetine is a synthetic compound derived from vincamine, a substance found in the periwinkle plant. It has been studied for potential neuroprotective, anti-inflammatory, and antioxidant effects. In clinical settings, it has shown some promise as an add-on treatment for focal epilepsy and may slow hearing loss progression, but human evidence for cognitive enhancement is currently weak and inconsistent.
What It Doesn't Do
Won't sharpen memory or focus in healthy adults — a clinical trial found no cognitive benefit at any tested dose. Not a proven brain booster despite heavy marketing as one. Animal study results have not translated reliably to humans. Not a standalone treatment for any neurological condition.
Evidence-Based Benefits
Vinpocetine shows some anti-inflammatory and antioxidant properties in preclinical and limited clinical settings; when combined with dexamethasone, it reduced inflammatory cytokines and improved cognitive scores in radiation-injured cancer patients (PMID: 32294652). As an adjunct treatment, extended-release vinpocetine (2 mg/kg/day) significantly reduced focal epileptic seizure frequency compared to placebo in a double-blind RCT (PMID: 31536041). Preclinical evidence suggests it may alleviate chemotherapy-induced peripheral neuropathy via mitochondrial biogenesis and oxidative stress reduction (PMID: 40774018), and reduce lung injury via NLRP3/NF-κB pathway inhibition (PMID: 40730088).
Weak EvidenceEffective at: No established dose for cognitive enhancement; 10-60 mg/day used in clinical studies with mixed results
Source: auto-research
Absorption & Bioavailability
Poor in humans relative to animals — clinical studies found blood levels of vinpocetine and its active metabolite (apovincaminic acid) were substantially lower in humans than in animals given equivalent doses, which may explain why animal study benefits don't translate.
Red Flags to Watch For
- FDA has questioned whether vinpocetine qualifies as a legal dietary supplement ingredient, as it is a synthetic pharmaceutical compound
- Pregnant women should avoid it — animal studies suggest it may affect fetal development, and it is not approved for use during pregnancy
- Human blood levels are far lower than levels shown to be effective in animal models, raising serious questions about whether standard supplement doses do anything
- Found in over 660 registered supplement products despite weak human evidence for its primary marketed use (cognitive enhancement)
- Adverse events including headache and double vision (diplopia) reported in clinical trials; post-market safety signals identified in pharmacovigilance databases
Research Sources
- PubMed
- NIH DSLD
This information is for educational purposes only and is not medical advice. Always consult a healthcare professional before starting any supplement regimen. Last updated: 2026-04-06